SRRK
Scholar Rock Holding Corporation · Healthcare · Biotechnology
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +5 | 87.18M | $4.79B | +10 | −4 |
| Q1 2026 | 102 | +4 | 76.34M | $3.75B | +8 | −5 |
| Q4 2025 | 97 | -1 | 72.93M | $3.21B | +2 | −2 |
| Q3 2025 | 19 | -2 | 52.36M | $1.95B | — | −3 |
| Q2 2025 | 19 | +1 | 48.51M | $1.72B | +1 | — |
| Q1 2025 | 15 | 0 | 24.83M | $798.16M | — | — |
| Q4 2024 | 15 | +1 | 26.21M | $1.13B | +2 | −1 |
| Q3 2024 | 13 | 0 | 15.70M | $125.78M | +1 | −1 |
| Q2 2024 | 13 | — | 12.73M | $106.08M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 8.19M | — | $68.21M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (passive) | 1.42M | — | $11.85M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Millennium Management ✦ | 925.58K | — | $7.71M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Two Sigma Investments ✦ | 800.67K | — | $6.67M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Marshall Wace ✦ | 487.29K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 254.04K | — | $2.12M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 171.98K | — | $1.43M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Adage Capital Partners ✦ | 125.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 113.00K | — | $941,257 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Fisher Asset Management ✦ | 105.83K | — | $881,588 | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 92.36K | — | $769,392 | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 39.75K | — | $331,150 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | Point72 Asset Management ✦ | 8.19K | — | $68,247 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 274 holders, 132.63M shares, $6.20B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.